To vaccinate or not to vaccinate? Experiences of COVID-19 vaccine uptake among people living with non-communicable diseases in Ghana: A qualitative study.

Following the development of a vaccine for COVID-19, the expectation was instantaneous widespread distribution and uptake to halt further spread, severe illness and deaths from the virus. However, studies show very low uptake, especially in resource-poor settings, and little is documented about the...

Full description

Saved in:
Bibliographic Details
Main Authors: Leonard Baatiema, Sheba M P Kunfah, Olutobi A Sanuade, Luke N Allen, Seye Abimbola, Ama de-Graft Aikins, Kwadwo A Koram, Margaret E Kruk
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLOS Global Public Health
Online Access:https://doi.org/10.1371/journal.pgph.0003820
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849715403294507008
author Leonard Baatiema
Leonard Baatiema
Sheba M P Kunfah
Olutobi A Sanuade
Luke N Allen
Seye Abimbola
Ama de-Graft Aikins
Kwadwo A Koram
Margaret E Kruk
author_facet Leonard Baatiema
Leonard Baatiema
Sheba M P Kunfah
Olutobi A Sanuade
Luke N Allen
Seye Abimbola
Ama de-Graft Aikins
Kwadwo A Koram
Margaret E Kruk
author_sort Leonard Baatiema
collection DOAJ
description Following the development of a vaccine for COVID-19, the expectation was instantaneous widespread distribution and uptake to halt further spread, severe illness and deaths from the virus. However, studies show very low uptake, especially in resource-poor settings, and little is documented about the drivers of vaccine uptake in populations classified as high-risk. In this study, we explored access and uptake of COVID-19 vaccines among people living with non-communicable diseases (PLWNCDs) in Ghana. A qualitative study using in-depth interviews and focus group discussions was conducted among adults (>18 years) PLWNCDs stratified by sex, age, and type of non-communicable diseases (NCDs) at the community level (non-users of the health service) and health facility levels. Purposive sampling was used to select eligible participants. Topic guides were used to facilitate the face-to-face in-depth interviews and focus group discussions. The interviews and discussions were all digitally audio recorded. All transcripts and field notes were thematically analysed. Overall, 62 participants were recruited for this study. Family members, friends/peers, health workers and media were identified as the main sources of information for COVID-19 vaccines. Several barriers that mediated access to the COVID-19 vaccines in Ghana were reported including mistrust of vaccine efficacy and fears of vaccine side-effects, long distance to and waiting hours at vaccination centres, shortages of vaccines at vaccination centres and non-prioritization of NCD patients for the vaccine. To improve uptake, intensified education and sensitization, house-to-house vaccination, expansion of vaccination centers and increased supply of vaccines were recommended by participants. Compared to studies elsewhere, misinformation and disinformation were not major causes of vaccine hesitancy. If policymakers can improve community-based vaccine delivery, reduce queues and waiting times, prioritize PLWNCDs and other vulnerable groups, and improve sensitization and communication-our findings suggest there will be major improvements in COVID-19 vaccine coverage in Ghana.
format Article
id doaj-art-a1dab60c68ec40268a7a7b0d61239b68
institution DOAJ
issn 2767-3375
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLOS Global Public Health
spelling doaj-art-a1dab60c68ec40268a7a7b0d61239b682025-08-20T03:13:23ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752024-01-01410e000382010.1371/journal.pgph.0003820To vaccinate or not to vaccinate? Experiences of COVID-19 vaccine uptake among people living with non-communicable diseases in Ghana: A qualitative study.Leonard BaatiemaLeonard BaatiemaSheba M P KunfahOlutobi A SanuadeLuke N AllenSeye AbimbolaAma de-Graft AikinsKwadwo A KoramMargaret E KrukFollowing the development of a vaccine for COVID-19, the expectation was instantaneous widespread distribution and uptake to halt further spread, severe illness and deaths from the virus. However, studies show very low uptake, especially in resource-poor settings, and little is documented about the drivers of vaccine uptake in populations classified as high-risk. In this study, we explored access and uptake of COVID-19 vaccines among people living with non-communicable diseases (PLWNCDs) in Ghana. A qualitative study using in-depth interviews and focus group discussions was conducted among adults (>18 years) PLWNCDs stratified by sex, age, and type of non-communicable diseases (NCDs) at the community level (non-users of the health service) and health facility levels. Purposive sampling was used to select eligible participants. Topic guides were used to facilitate the face-to-face in-depth interviews and focus group discussions. The interviews and discussions were all digitally audio recorded. All transcripts and field notes were thematically analysed. Overall, 62 participants were recruited for this study. Family members, friends/peers, health workers and media were identified as the main sources of information for COVID-19 vaccines. Several barriers that mediated access to the COVID-19 vaccines in Ghana were reported including mistrust of vaccine efficacy and fears of vaccine side-effects, long distance to and waiting hours at vaccination centres, shortages of vaccines at vaccination centres and non-prioritization of NCD patients for the vaccine. To improve uptake, intensified education and sensitization, house-to-house vaccination, expansion of vaccination centers and increased supply of vaccines were recommended by participants. Compared to studies elsewhere, misinformation and disinformation were not major causes of vaccine hesitancy. If policymakers can improve community-based vaccine delivery, reduce queues and waiting times, prioritize PLWNCDs and other vulnerable groups, and improve sensitization and communication-our findings suggest there will be major improvements in COVID-19 vaccine coverage in Ghana.https://doi.org/10.1371/journal.pgph.0003820
spellingShingle Leonard Baatiema
Leonard Baatiema
Sheba M P Kunfah
Olutobi A Sanuade
Luke N Allen
Seye Abimbola
Ama de-Graft Aikins
Kwadwo A Koram
Margaret E Kruk
To vaccinate or not to vaccinate? Experiences of COVID-19 vaccine uptake among people living with non-communicable diseases in Ghana: A qualitative study.
PLOS Global Public Health
title To vaccinate or not to vaccinate? Experiences of COVID-19 vaccine uptake among people living with non-communicable diseases in Ghana: A qualitative study.
title_full To vaccinate or not to vaccinate? Experiences of COVID-19 vaccine uptake among people living with non-communicable diseases in Ghana: A qualitative study.
title_fullStr To vaccinate or not to vaccinate? Experiences of COVID-19 vaccine uptake among people living with non-communicable diseases in Ghana: A qualitative study.
title_full_unstemmed To vaccinate or not to vaccinate? Experiences of COVID-19 vaccine uptake among people living with non-communicable diseases in Ghana: A qualitative study.
title_short To vaccinate or not to vaccinate? Experiences of COVID-19 vaccine uptake among people living with non-communicable diseases in Ghana: A qualitative study.
title_sort to vaccinate or not to vaccinate experiences of covid 19 vaccine uptake among people living with non communicable diseases in ghana a qualitative study
url https://doi.org/10.1371/journal.pgph.0003820
work_keys_str_mv AT leonardbaatiema tovaccinateornottovaccinateexperiencesofcovid19vaccineuptakeamongpeoplelivingwithnoncommunicablediseasesinghanaaqualitativestudy
AT leonardbaatiema tovaccinateornottovaccinateexperiencesofcovid19vaccineuptakeamongpeoplelivingwithnoncommunicablediseasesinghanaaqualitativestudy
AT shebampkunfah tovaccinateornottovaccinateexperiencesofcovid19vaccineuptakeamongpeoplelivingwithnoncommunicablediseasesinghanaaqualitativestudy
AT olutobiasanuade tovaccinateornottovaccinateexperiencesofcovid19vaccineuptakeamongpeoplelivingwithnoncommunicablediseasesinghanaaqualitativestudy
AT lukenallen tovaccinateornottovaccinateexperiencesofcovid19vaccineuptakeamongpeoplelivingwithnoncommunicablediseasesinghanaaqualitativestudy
AT seyeabimbola tovaccinateornottovaccinateexperiencesofcovid19vaccineuptakeamongpeoplelivingwithnoncommunicablediseasesinghanaaqualitativestudy
AT amadegraftaikins tovaccinateornottovaccinateexperiencesofcovid19vaccineuptakeamongpeoplelivingwithnoncommunicablediseasesinghanaaqualitativestudy
AT kwadwoakoram tovaccinateornottovaccinateexperiencesofcovid19vaccineuptakeamongpeoplelivingwithnoncommunicablediseasesinghanaaqualitativestudy
AT margaretekruk tovaccinateornottovaccinateexperiencesofcovid19vaccineuptakeamongpeoplelivingwithnoncommunicablediseasesinghanaaqualitativestudy